Novo CEO pressed by Senate to chop prices of weight problems, diabetic issues medicine CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers in regards to the listing prices of Wegovy and copyright if they pledge to keep the medicines on their own formularies.Really don't miss out on tomorrow's healt… Read More


FTC sues major pharmacy benefit managers around insulin prices The company introduced motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of daily life-preserving insulin medication.Exactly where are the many nurses? Hospitals, advocate… Read More